# AI in Medicine: The Top Two Priorities | Susan Desmond-Hellmann M.D., M.P.H

**Channel:** Peter Attia MD
**Upload Date:** 2025-04-30
**URL:** https://www.youtube.com/watch?v=axEWK1VuAFo
**Duration:** 5 minutes

## Description

Get An Introductory Guide to Longevity and my weekly newsletter here (free): https://bit.ly/4lH8U3D
Watch the full episode: https://youtu.be/ib88qkNY3LQ
Become a member to receive exclusive content: https://bit.ly/3O0pEnY

This clip is from episode 346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

In this clip, they discuss:

- AI and Clinical Trials – Using AI to streamline trial design and reduce the time to drug approval, without sacrificing patient safety
- Shaving Years Off the Drug Pipeline – How AI could cut trial timelines by up to two years by handling labor-intensive paperwork and reporting
- Fighting Burnout with Smarter Systems – Exploring how AI could reduce physician and nurse burnout by improving charting and administrative workflows
- AI’s Real Strength: Synthesizing Data – It’s not just about speed—AI connects disparate data points to help caregivers make better decisions
- Why Hospitals Need AI Support Tools – From medical reconciliation to bedside observations, AI could help ease the burden on overworked systems

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's my analysis of this clip from The Drive podcast:

1. **Executive Summary**:
This episode features Dr. Susan Desmond-Hellmann discussing her role on the OpenAI board and the potential applications of AI in medicine. The conversation focuses primarily on two main priorities: streamlining clinical trials and reducing healthcare worker burnout. She emphasizes that AI should be used to optimize processes without compromising the fundamental aspects of clinical research and patient care.

2. **Key Medical/Scientific Points**:
- Clinical trials typically take about 6 years from IND to approval [02:22]
- Potential to reduce clinical trial duration by 2 years using AI [02:22]
- Current safety trials typically involve only 500 patients, which is limited [03:52]
- Discussion of using AI for ongoing safety monitoring across all patients [03:52]

3. **Health Optimization Tips**:
Universal recommendations:
- None specifically mentioned

4. **Notable Quotes**:
"I still want to know does your tumor shrink? Do you feel better? Do you have side effects? But there's a lot of study reports... that are actually very important to establishing the safety and efficacy of a drug." [01:32]

5. **References & Resources**:
Experts mentioned:
- Dr. Susan Desmond-Hellmann - OpenAI board member [00:00]
Organizations mentioned:
- OpenAI [00:21]
- FDA (referenced in discussion about regulatory changes) [02:49]
- University of Washington [05:09]
- UCSF [05:09]

6. **Follow-up Questions**:
1. What specific AI tools are currently being developed for clinical trial optimization?
2. How will AI integration affect medical education and training?
3. What are the potential risks of implementing AI in healthcare settings?
4. How will patient privacy be maintained with increased AI usage in healthcare?

Note: The clip focuses primarily on AI applications in medicine and clinical trials. Many of the requested categories (Supplements & Medications, Exercise & Movement, Nutrition & Diet, Biomarkers & Testing) were not discussed in this segment.

The two main priorities for AI in medicine according to Dr. Desmond-Hellmann are:
1. Streamlining clinical trials and drug development processes [01:32]
2. Reducing healthcare worker burnout through workflow optimization [03:52]
